Factory Free sample Tetracaine - Olaparib AZD-2281 CAS 763113-22-0 Purity ≥99.0% API Factory – Ruifu
Factory Free sample Tetracaine - Olaparib AZD-2281 CAS 763113-22-0 Purity ≥99.0% API Factory – Ruifu Detail:
Supply With High Purity, Commercial Production
Chemical Name | Olaparib |
Synonyms | AZD-2281; KU0059436; Lynparza; 4-(3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)Methyl]-2-fluorobenzoyl]piperazin |
CAS Number | 763113-22-0 |
CAT Number | RF-API103 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C24H23FN4O3 |
Molecular Weight | 434.46 |
Solubility | Soluble in DMSO |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Identification by 1H NMR | Comply with the structure |
LC-MS | Comply with the structure |
Purity / Analysis Method | ≥99.0% (by LC-MS) |
Moisture (K.F) | ≤0.50% |
Single Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Heavy Metals (as Pb) | ≤20ppm |
Test Standard | Enterprise Standard |
Usage | API; PARP Inhibitor |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
Olaparib (CAS: 763113-22-0), a highly potent and selective PARP-inhibitor. In December 19, 2014, the FDA approved novel anti-cancer drug Olaparib (Lynparza) for monotherapy to the patients of advanced ovarian cancer who has undergone at least 3 rounds of chemotherapy or patients of suspected BRCA mutations. At the same time, FDA approved the quantitation and classification of diagnostic kits for the detection of mutations in BRCA1 and BRCA2, BRACAnalysis CDx. Olaparib is the first PARP inhibitor drugs which has been approved by FDA. In February 2, 2015, the European Union Food and Drug Administration (EMA) also approved Olaparib to enter into market in the 28 countries of European Union including Iceland, Liechtenstein and Norway. But the indications of EMA and FDA approved are slightly different; the former is for the BRCA gene mutation cases, and also for the maintenance therapy for patients of advanced epithelial ovarian cancer who has previously received platinum-containing chemotherapy drugs and exhibit response and subject to recurrence.
Product detail pictures:
Related Product Guide:
Our mission will be to grow to be an innovative supplier of high-tech digital and communication devices by giving worth added design and style, world-class production, and service capabilities for Factory Free sample Tetracaine - Olaparib AZD-2281 CAS 763113-22-0 Purity ≥99.0% API Factory – Ruifu , The product will supply to all over the world, such as: St. Petersburg, Paraguay, Bolivia, Faced with the vitality of the global wave of economic integration, we are confident with our high-quality products and sincerely service to all our customers and wish we can cooperate with you to create a brilliant future.
By Riva from Argentina - 2017.12.09 14:01
We have been cooperated with this company for many years, the company always ensure timely delivery ,good quality and correct number, we are good partners.
By Janice from New Zealand - 2017.10.25 15:53